Indirect psychiatric consultation for perinatal bipolar disorder: A scoping review

Gen Hosp Psychiatry. 2021 Jan-Feb:68:19-24. doi: 10.1016/j.genhosppsych.2020.11.011. Epub 2020 Nov 25.

Abstract

Objective: To synthesize the literature and develop guidance on supports needed for primary care and perinatal providers in screening, initial management, triage, and bridging treatment for perinatal bipolar disorder.

Methods: We conducted a scoping review by searching six electronic databases using keywords related to perinatal bipolar disorder. We summarized descriptive statistics on settings and extracted information on care approaches. We synthesized the literature on indirect care models and extracted data on screening, follow-up, referrals, and management.

Results: 1169 articles were retrieved. 51 articles were included after review. Most papers were reviews. Fewer addressed care in obstetric (n = 20, 39%), primary care (n = 10, 20%), and pediatric settings (n = 2, 4%). Most papers (n = 30, 59%) discussed using screening instruments for bipolar disorder. Articles were mixed on recommendations for bipolar disorder screening.

Conclusions: Varied strategies for structured assessment exist and are influenced by practice setting. There remains uncertainty about optimal strategies for screening and management of perinatal bipolar disorder. We recommend screening for bipolar disorder in the perinatal period in select circumstances (with depression screening, known bipolar disorder risk factors, and prior to starting antidepressants). If specialty mental health care is unavailable, we recommend enhancing usual care through integrated care strategies such as indirect consultation.

Keywords: Bipolar disorder; Consultation; Perinatal; Postpartum; Pregnancy; Psychiatry.

Publication types

  • Scoping Review

MeSH terms

  • Antidepressive Agents
  • Bipolar Disorder* / diagnosis
  • Bipolar Disorder* / epidemiology
  • Bipolar Disorder* / therapy
  • Child
  • Female
  • Humans
  • Mass Screening
  • Pregnancy
  • Referral and Consultation

Substances

  • Antidepressive Agents